Legal status in the United States

Is TB-500 legal?

Read at FDA, DEA and WADAPublished by PepVault

TB-500 has no FDA-approved product, is not a federally controlled substance, and is banned in sport (WADA names it under S2.3), as of November 18, 2026.

TB-500 at a glance

CheckStatus, read Nov 18, 2026
FDA approvalNot approved
CompoundingNomination withdrawn; on no FDA list
DEA scheduleNot controlled
Sport (WADA)Banned, named (S2.3)

FDA approval

TB-500 has no FDA-approved product: Drugs@FDA lists no application for it or for thymosin beta-4.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

FDA once placed TB-500 (thymosin beta-4 fragment LKKTETQ) in category 2, its list of bulk substances that may raise significant safety risks; the nominations were then withdrawn, and FDA now lists it under “Bulk drug substances nominated but withdrawn.” It is in none of the three 503A categories on FDA’s list updated May 14, 2026, and not on the 503B bulks list. FDA took TB-500 to its Pharmacy Compounding Advisory Committee on July 23, 2026, for wound healing, and proposed that it “NOT be included” on the 503A bulks list; the committee’s vote is not on FDA’s meeting page, and TB-500 is not on the 503A bulks list itself (21 CFR 216.23).

The source: “Bulk drug substances nominated but withdrawn”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

WADA bans TB-500 at all times, in and out of competition: the 2026 list names it under S2.3, as a derivative of thymosin beta-4.

The source: “Thymosin-β4 and its derivatives e.g. TB-500”

How it is sold when it isn’t approved

FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

The source: falsely labeled “for research purposes” or “not for human consumption.”

What this means and doesn’t

This page reports what the agencies’ own pages said about TB-500 in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is TB-500 FDA approved?

    TB-500 has no FDA-approved product: Drugs@FDA lists no application for it or for thymosin beta-4.

  • Is TB-500 a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is TB-500 banned in sport?

    WADA bans TB-500 at all times, in and out of competition: the 2026 list names it under S2.3, as a derivative of thymosin beta-4.

  • What does FDA say about compounding TB-500?

    FDA once placed TB-500 (thymosin beta-4 fragment LKKTETQ) in category 2, its list of bulk substances that may raise significant safety risks; the nominations were then withdrawn, and FDA now lists it under “Bulk drug substances nominated but withdrawn.” It is in none of the three 503A categories on FDA’s list updated May 14, 2026, and not on the 503B bulks list. FDA took TB-500 to its Pharmacy Compounding Advisory Committee on July 23, 2026, for wound healing, and proposed that it “NOT be included” on the 503A bulks list; the committee’s vote is not on FDA’s meeting page, and TB-500 is not on the 503A bulks list itself (21 CFR 216.23).

  • What does FDA say about the “research use only” label?

    FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo